Study of the Chelating Properties of Ge(OH)2 Functionality As Metal Binding Group for Zn2+ Cation in Simplified Protease-like Environments: a DFT Analysis

Overview

Journal J Mol Model

Publisher Springer

Specialty Molecular Biology

Date 2014 Aug 22

PMID 25142338

Citations 1

Authors

Pilar Gema Rodriguez Ortega

Manuel Montejo

Juan Jesus Lopez Gonzalez

Affiliations

Soon will be listed here.

Abstract

The development of protease's inhibitors is an active field of research in the pharmaceutical industry. As concerns the design of new inhibitors, the theoretical study of the binding patterns and energies of known metal binding groups (MBGs) toward Zn(2+) using quantum-chemical calculations may offer a better understanding of their interaction models and may be useful for the improvement and design of novel ZBGs. Here the properties of gem-Ge(OH)(2)-based compounds as ZBG were assessed theoretically using DFT calculations. [Zn(Imdz)(2) R - OH(2)](2+) complexes (Imdz =imidazole rings; R = imidazole ring, acetic acid molecule or acetate anion) were used to partially reproduce the coordination sphere in metalloproteases (ACE, amgiotensin converting enzyme, and TLN, thermolysine) being inhibited by related compounds (i.e., silanediols). The MBG- Zn(2+) interaction was analyzed through the energy of the reaction: [Zn(Imdz)(2) R - OH(2)](2+) + L → [Zn(Imdz)(2) R - L](2+) + H(2)O using DFT (M06L/cc-pVDZ) in gas-phase and in solution (IEF-PCM). Although the functional used (M06L) has proven its efficiency to study systems containing transition metal governed by non-covalent interactions, dispersion effects were implemented by the correction of the computed energies using the DFT-D3 program. Accounting for dispersion effects produced a systematic increase of c.a. 13 kJ mol(-1) on the energies, whereas the effect of solvent goes in the opposite direction (i.e., BE under the IEF-PCM model are on average 125 kJ mol(-1) lower). The Ge(OH)(2) - Zn(2+) interaction seems to be similar (or even stronger) than the Si(OH)(2) -Zn(2+). Their better performance as ZBG is explained by the combined NBO-AIM analysis. The results of this work may encourage the preparation, isolation, and experimental assay of the chelating properties of these compounds, which may propose a new family of protease's inhibitors.

Citing Articles

Study of the chelating properties of Ge(OH)2 functionality as metal binding group for Zn2+ cation in simplified protease-like environments: a DFT analysis.

Rodriguez Ortega P, Montejo M, Lopez Gonzalez J J Mol Model. 2014; 20(9):2430.

PMID: 25142338 DOI: 10.1007/s00894-014-2430-2.

References

Ignatyev I, Montejo M, Rodriguez Ortega P, Lopez Gonzalez J . Quantum chemical study of silanediols as metal binding groups for metalloprotease inhibitors. J Mol Model. 2013; 19(4):1819-34. DOI: 10.1007/s00894-012-1745-0. View

Nielsen L, Skrydstrup T . Sequential C-Si bond formations from diphenylsilane: application to silanediol peptide isostere precursors. J Am Chem Soc. 2008; 130(39):13145-51. DOI: 10.1021/ja804720p. View

Cramer C, Truhlar D . Density functional theory for transition metals and transition metal chemistry. Phys Chem Chem Phys. 2009; 11(46):10757-816. DOI: 10.1039/b907148b. View

Zhao Y, Truhlar D . A new local density functional for main-group thermochemistry, transition metal bonding, thermochemical kinetics, and noncovalent interactions. J Chem Phys. 2006; 125(19):194101. DOI: 10.1063/1.2370993. View

Tacke R, Wannagat U . Syntheses and properties of bioactive organo-silicon compounds. Top Curr Chem. 1979; 84:1-75. DOI: 10.1007/BFb0048522. View

Bo Y, Singh S, Duong H, Cao C, Sieburth S . Efficient, enantioselective assembly of silanediol protease inhibitors. Org Lett. 2011; 13(7):1787-9. PMC: 3064730. DOI: 10.1021/ol2002978. View

Frison G, Ohanessian G . A comparative study of semiempirical, ab initio, and DFT methods in evaluating metal-ligand bond strength, proton affinity, and interactions between first and second shell ligands in Zn-biomimetic complexes. J Comput Chem. 2007; 29(3):416-33. DOI: 10.1002/jcc.20800. View

McCall K, Huang C, Fierke C . Function and mechanism of zinc metalloenzymes. J Nutr. 2000; 130(5S Suppl):1437S-46S. DOI: 10.1093/jn/130.5.1437S. View

Schonbohm J . Update of the AIM2000-program for atoms in molecules. J Comput Chem. 2002; 23(15):1489-94. DOI: 10.1002/jcc.10085. View

10.

Chen C, Sieburth S, Glekas A, Hewitt G, Trainor G, Garber S . Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease. Chem Biol. 2002; 8(12):1161-6. DOI: 10.1016/s1074-5521(01)00079-5. View

11.

Kimura E . Model studies for molecular recognition of carbonic anhydrase and carboxypeptidase. Acc Chem Res. 2001; 34(2):171-9. DOI: 10.1021/ar000001w. View

12.

Rodriguez Ortega P, Montejo M, Lopez Gonzalez J . Study of the chelating properties of Ge(OH)2 functionality as metal binding group for Zn2+ cation in simplified protease-like environments: a DFT analysis. J Mol Model. 2014; 20(9):2430. DOI: 10.1007/s00894-014-2430-2. View

13.

Gupta S . Quantitative structure-activity relationship studies on zinc-containing metalloproteinase inhibitors. Chem Rev. 2007; 107(7):3042-87. DOI: 10.1021/cr030448t. View

14.

Zeng Y, Wang S, Feng H, Xie Y, King R . Highly unsaturated binuclear butadiene iron carbonyls: quintet spin states, perpendicular structures, agostic hydrogen atoms, and iron-iron multiple bonds. Int J Mol Sci. 2011; 12(4):2216-31. PMC: 3127113. DOI: 10.3390/ijms12042216. View

15.

Grimme S, Antony J, Ehrlich S, Krieg H . A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J Chem Phys. 2010; 132(15):154104. DOI: 10.1063/1.3382344. View

16.

Kim J, Glekas A, Sieburth S . Silanediol-based inhibitor of thermolysin. Bioorg Med Chem Lett. 2002; 12(24):3625-7. DOI: 10.1016/s0960-894x(02)00804-1. View

17.

Mutahi M, Nittoli T, Guo L, Sieburth S . Silicon-based metalloprotease inhibitors: synthesis and evaluation of silanol and silanediol peptide analogues as inhibitors of angiotensin-converting enzyme. J Am Chem Soc. 2002; 124(25):7363-75. DOI: 10.1021/ja026158w. View

18.

Wyvratt M, PATCHETT A . Recent developments in the design of angiotensin-converting enzyme inhibitors. Med Res Rev. 1985; 5(4):483-531. DOI: 10.1002/med.2610050405. View

19.

Wu Y, Gellman S . Peptidomimetics. Acc Chem Res. 2008; 41(10):1231-2. DOI: 10.1021/ar800216e. View

20.

Smiesko M, Remko M . Coordination and thermodynamics of stable Zn(II) complexes in the gas phase. J Biomol Struct Dyn. 2003; 20(6):759-70. DOI: 10.1080/07391102.2003.10506893. View